Relation of High Concentrations of Plasma Carboxy-Terminal Telopeptide of Collagen Type I With Outcome in Acute Myocardial Infarction

American Journal of Cardiology

Volumn 104, Issue 7, 2009, Pages 904-909

  Barthélémy, Olivier ^a   Beygui, Farzin ^a   Vicaut, Eric ^b   Rouanet, Stephanie ^c   Van Belle, Eric ^d   Baulac, Cathrine ^c   Degrandsart, Alexia ^c   Dallongeville, Jean ^e   Montalescot, Gilles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Hopital F VIDAL   (France)

^c PFIZER INC   (United States)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARBOXY TERMINAL TELOPEPTIDE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; ASSAULT; COLLAGEN DEGRADATION; FEMALE; HEART ARREST; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

EID: 70249121825     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.029     Document Type: Article

References (29)

1. Montalescot G., Dallongeville J., Van Belle E., Rouanet S., Baulac C., Degrandsart A., and Vicaut E. STEMI and NSTEMI: are they so different?. 1 Year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28 (2007) 1409-1417
2. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 21 (2000) 1502-1513
3. Whittaker P., Boughner D.R., and Kloner R.A. Role of collagen in acute myocardial infarct expansion. Circulation 84 (1991) 2123-2134
4. Pfeffer M.A., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
5. Herzog, and Kohmoto T. Early activation of metalloproteinases after experimental myocardial infarction occurs in infarct and non-infarct zones. EG, A. Cardiovasc Pathol (1998) 307-312
6. Danielsen C.C., Wiggers H., and Andersen H.R. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. J Mol Cell Cardiol 30 (1998) 1431-1442
7. McGavigan A.D., Moncrieff J., Lindsay M.M., Maxwell P.R., and Dunn F.G. Time course of plasma markers of collagen turnover in patients with acute myocardial infarction. Heart 90 (2004) 1053-1054
8. Cleutjens J.P., Kandala J.C., Guarda E., Guntaka R.V., and Weber K.T. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27 (1995) 1281-1292
9. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13 (1989) 1637-1652
10. Risteli J., Elomaa I., Niemi S., Novamo A., and Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39 (1993) 635-640
11. Lopez B., Gonzalez A., Varo N., Laviades C., Querejeta R., and Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 38 (2001) 1222-1226
12. Murakami T., Kusachi S., Murakami M., Sano I., Uesugi T., Hirami R., Kajiyama A., Kondo J., and Tsuji T. Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices. Clin Chem 44 (1998) 2453-2461
13. McGavigan A.D., Maxwell P.R., and Dunn F.G. Serological evidence of early remodeling in high-risk non-ST elevation acute coronary syndromes. Int J Cardiol 125 (2008) 22-27
14. McGavigan A.D., Maxwell P.R., and Dunn F.G. Serological evidence of altered collagen homeostasis reflects early ventricular remodeling following acute myocardial infarction. Int J Cardiol 111 (2006) 267-274
15. St John Sutton M., Pfeffer M.A., Moye L., Plappert T., Rouleau J.L., Lamas G., Rouleau J., Parker J.O., Arnold M.O., Sussex B., and Braunwald E. Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 96 (1997) 3294-3299
16. Cerisano G., Bolognese L., Carrabba N., Buonamici P., Santoro G.M., Antoniucci D., Santini A., Moschi G., and Fazzini P.F. Doppler-derived mitral deceleration time: an early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 99 (1999) 230-236
17. Kober L., Torp-Pedersen C., Carlsen J., Videbaek R., and Egeblad H. An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation. Eur Heart J 15 (1994) 1616-1620
18. Cerisano G., Pucci P.D., Sulla A., Tommasi M., Raspanti S., Santoro G.M., and Antoniucci D. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 99 (2007) 651-656
19. Kostuk W.J., Kazamias T.M., Gander M.P., Simon A.L., and Ross Jr. J. Left ventricular size after acute myocardial infarction: serial changes and their prognostic significance. Circulation 47 (1973) 1174-1179
20. Jirmar R., Pelouch V., Widimsky P., Capek J., Andel M., Prusa R., and Pechova M. Influence of primary coronary intervention on myocardial collagen metabolism and left ventricle remodeling predicted by collagen metabolism markers. Int Heart J 46 (2005) 949-959
21. Creemers E.E., Cleutjens J.P., Smits J.F., and Daemen M.J. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ Res 89 (2001) 201-210
22. Kameda K., Matsunaga T., Abe N., Hanada H., Ishizaka H., Ono H., Saitoh M., Fukuda I., Osanai T., and Okumura K. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease. Possible role for left ventricular remodelling. Eur Heart J 24 (2003) 2180-2185
23. Schonbeck U., Mach F., Sukhova G.K., Murphy C., Bonnefoy J.Y., Fabunmi R.P., and Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?. Circ Res 81 (1997) 448-454
24. Mega J.L., Morrow D.A., De Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., Gibson C.M., Antman E.M., and Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an entire-TIMI-23 substudy. J Am Coll Cardiol 44 (2004) 335-339
25. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., and Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
26. Tsuruda T., Boerrigter G., Huntley B.K., Noser J.A., Cataliotti A., Costello-Boerrigter L.C., Chen H.H., and Burnett Jr. J.C. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91 (2002) 1127-1134
27. Rohde L.E., Ducharme A., Arroyo L.H., Aikawa M., Sukhova G.H., Lopez-Anaya A., McClure K.F., Mitchell P.G., Libby P., and Lee T. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99 (1999) 3063-3070
28. Spinale F.G., Escobar G.P., Hendrick J.W., Clark L.L., Camens S.S., Mingoia J.P., Squires C.G., Stroud R.E., and Ikonomidis J.S. Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: differential effects on short and long-term survival. J Pharmacol Exp Ther 318 (2006) 966-973
29. Villarreal F.J., Griffin M., Omens J., Dillmann W., Nguyen J., and Covell J. Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. Circulation 108 (2003) 1487-1492